Conversion Therapy Harms Heart Health
Medically reviewed by Drugs.com.
By Dennis Thompson HealthDay Reporter
WEDNESDAY, May 7, 2025 -- Conversion therapy might harm a young person’s long-term heart health, a new study says.
Young adults assigned male at birth were nearly three times as likely to be diagnosed with high blood pressure if they’d been exposed to conversion therapy, a discredited practice that attempts to alter a person’s sexual orientation or gender identity, researchers reported May 6 in JAMA Network Open.
These young adults also had higher levels of inflammation and elevated blood pressure levels, both of which are potentially damaging to heart health, researchers report.
“This is the first study, to our knowledge, to document elevated blood pressure and systemic inflammation, important factors shaping the risk of adverse cardiovascular health outcomes, among sexual and gender minority people exposed to [conversion therapy],” concluded the research team led by senior author Brian Mustanski, director of the Institute for Sexual and Gender Minority Health and Wellbeing at Northwestern University in Chicago.
For the study, researchers analyzed health data on more than 700 young adults assigned male gender at birth, of whom 23% were transgender or gender diverse.
About 10% of participants said they’d been put through conversion therapy, which tries to alter same-sex attractions or change sexual minority identity.
“These interventions, rooted in discredited beliefs that sexual and gender minority identities, behaviors, and/or attractions are immoral, abnormal, and/or pathological, have been unequivocally denounced by leading medical, psychological, and human rights organizations based on their harmful psychological impacts,” researchers said in background notes.
“The detrimental psychological effects of (conversion therapy) include heightened risk of depression, anxiety, and suicidality,” researchers added.
Researchers tested heart health measures including blood pressure and blood markers for inflammation, and asked participants if they’d been diagnosed with high blood pressure.
Results showed that people sent through conversion therapy were nearly 2.9 times as likely to have been diagnosed with high blood pressure, even though their average age was around 27.
They also were more likely to have elevated blood pressure at the time of the researchers’ health check, and their blood showed more markers for inflammation.
The findings “support bans on (conversion therapy) and enforcement of existing bans to eventually eliminate the adverse health consequences associated with these practices,” researchers concluded.
“Although awareness of the harm caused by (conversion therapy) is increasing, legal bans remain inconsistent across the US,” researchers said. “Policymakers should consider these results when shaping laws to protect sexual and gender minority individuals from further harm.”
Sources
Disclaimer: Statistical data in medical articles provide general trends and do not pertain to individuals. Individual factors can vary greatly. Always seek personalized medical advice for individual healthcare decisions.
Source: HealthDay
Posted : 2025-05-08 00:00
Read more

- Magnetic Stimulation Aids Speech Recovery Following Stroke
- More Than 3.6 Million Births Recorded in the United States in 2024, Up 1 Percent From 2023
- FDA Approves Imaavy (nipocalimab-aahu) for the Treatment of Generalized Myasthenia Gravis (gMG)
- Roux-en-Y Gastric Bypass, Sleeve Gastrectomy Beat Adjustable Gastric Banding for Severe Obesity
- Prostate Cancer Screening Program Beneficial in Top Decile of Polygenic Risk Score
- Medicare Advantage Plans Squeezing Billions More From U.S. Government
Disclaimer
Every effort has been made to ensure that the information provided by Drugslib.com is accurate, up-to-date, and complete, but no guarantee is made to that effect. Drug information contained herein may be time sensitive. Drugslib.com information has been compiled for use by healthcare practitioners and consumers in the United States and therefore Drugslib.com does not warrant that uses outside of the United States are appropriate, unless specifically indicated otherwise. Drugslib.com's drug information does not endorse drugs, diagnose patients or recommend therapy. Drugslib.com's drug information is an informational resource designed to assist licensed healthcare practitioners in caring for their patients and/or to serve consumers viewing this service as a supplement to, and not a substitute for, the expertise, skill, knowledge and judgment of healthcare practitioners.
The absence of a warning for a given drug or drug combination in no way should be construed to indicate that the drug or drug combination is safe, effective or appropriate for any given patient. Drugslib.com does not assume any responsibility for any aspect of healthcare administered with the aid of information Drugslib.com provides. The information contained herein is not intended to cover all possible uses, directions, precautions, warnings, drug interactions, allergic reactions, or adverse effects. If you have questions about the drugs you are taking, check with your doctor, nurse or pharmacist.
Popular Keywords
- metformin obat apa
- alahan panjang
- glimepiride obat apa
- takikardia adalah
- erau ernie
- pradiabetes
- besar88
- atrofi adalah
- kutu anjing
- trakeostomi
- mayzent pi
- enbrel auto injector not working
- enbrel interactions
- lenvima life expectancy
- leqvio pi
- what is lenvima
- lenvima pi
- empagliflozin-linagliptin
- encourage foundation for enbrel
- qulipta drug interactions